Skip to content

CapEx at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$2.57M-51.6%
ALN
Alnylam PharmaceuticalsALNY
$21.83M+143%
Vir Biotechnology, Inc. logo
Vir Biotechnology, Inc.VIR
$390K-76.1%
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
$4.44M-1.4%
Absci Corporation logo
Absci CorporationABSI
$30K+20.0%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$3.83M-64.0%

Other financials

Income statement

See full
Revenue$8.2M-12.8%
Operating income-$11.4M-14.4%
Net income-$9.1M-3.0%
EPS (diluted)-$0.54+53.8%

Balance sheet

See full
Cash & equivalents$31.1M+32.9%
Total debt$2.5M-17.5%
Total equity$198.6M+632%
Total assets$235.5M+138%

Cash flow

See full
Operating cash flow-$22.1M+5.7%
Free cash flow-$22.1M+5.6%

Valuation

See full
Market cap$480.77M+262%
Enterprise value$452.14M+302%
P/S6.8×+2.6×

Profitability

See full
Operating margin-116.8%-26.1pp
Net margin-103.6%-22.7pp
FCF margin-150%-231pp

Returns & leverage

See full
Return on equity-36.9%-15.1pp
Debt / equity-0.1×
Current ratio6.6×+4.6×

Where this comes from

Reported directly by Assembly Biosciences in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: Assembly Biosciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Assembly Biosciences's capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Assembly Biosciences's capex?
Assembly Biosciences (ASMB) reported capex of $19K in Q1 2026.
What is the long-term trend for Assembly Biosciences's capex?
Over 2 years (2022 to 2025), Assembly Biosciences's capex has grown at a -19.6% compound annual growth rate (CAGR), from $102K to $66K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.